SFDA CEO Discusses Investment Opportunities with US Medical Companies

Saudi Food and Drug Authority (SFDA) CEO Dr. Hisham bin Saad Al-Jadhei received a delegation of about 40 US medical company representatives at the authority's headquarters in Riyadh today to discuss investment opportunities in the Kingdom's health sector.

 Al-Jadhei highlighted key investment opportunities in the Kingdom's health sector, emphasizing the authority's commitment to enhancing the investment environment and supporting the growth and expansion of medical companies. He also reviewed the regulatory systems, legislation, and mechanisms in place to promote investment in the health sector.

 This meeting comes in the framework of the SFDA's efforts to build international partnerships and enhance investments in the health sector, aiming to improve the quality of health services and support the Kingdom's health transformation process.